# Altermune Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/altermune-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Irvine, US
- Website: www.altermune.com
- Total disclosed funding: $7M
- Latest round: Seed (Sep 22, 2011)
- Investors on record: 1

## About

Altermune Technologies, LLC is a company specializing in the sale and leasing of domain names, providing accessible online assets for businesses and individuals aiming to enhance their digital branding.Altermune Technologies, LLC, founded in 2011 and headquartered in Irvine, US, focuses on domain name sales and leasing. The company has engaged in 2 deals, with the most recent deal on January 19, 2016, involving Centauri Therapeutics’ acquisition of the Alphamer technology for drug discovery. The founder's specific background details are not available.Altermune.com specializes in the sale and leasing of domain names, offering a straightforward platform for individuals and businesses seeking to acquire online assets. Their core service includes providing the option to purchase a domain name outright for USD 9,995 or to choose a leasing arrangement with a monthly payment plan of USD 480. This business model addresses the needs of entrepreneurs, startups, and established businesses looking to enhance their online presence by securing desirable domain names, catering to clients in diverse markets including North America, Europe, and Asia.The revenue model of Altermune.com is primarily structured around direct sales and leasing agreements for domain names. Clients engage with the company through purchases or leasing options, with transactions typically involving a one-time payment of USD 9,995 for outright sales or a monthly subscription fee of USD 480 for leasing. This model serves both B2B and direct-to-consumer markets, leveraging secure payment solutions to facilitate hassle-free transactions that appeal to a wide range of customers.Altermune Technologies plans to enhance its offerings with new products aimed at expanding its domain name inventory and improving user experience. The company is targeting growth in emerging markets, particularly in Asia-Pacific, by 2024. The recent Seed funding round of USD 7.00 mn from Loxbridge Research will support these initiatives and help facilitate the geographic expansion efforts.

## Funding rounds

- Seed, Sep 22, 2011, $7M — Loxbridge Research

## Investors

- Loxbridge Research (https://capitalatlas.ai/funds/loxbridge-research) — Seed